Alliances and Outsourcing Having Major Impact on Pharma Industry
Evidence of the growing emphasis on alliances and external collaborations as a route to success in the pharma industry is highlighted by the fact that partnerships within the biopharmaceutical sector are currently being formed at the rate of $5 billion per year, according to Arrowhead Publishers' new report Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and CRO Outsourcing (http://www.arrowheadpublishers.com/StrategiesforInnovationinPharmaceuticalRandD.html)
(PRWEB) March 22, 2005 -- The modern pharmaceutical company faces numerous
challenges in its efforts to improve productivity and to strengthen the product
portfolio. In an attempt to counteract the pressures of operating in a global
pharmaceutical market, companies have sought to establish relationships with
external partners such as biotechnology companies and Clinical Research
Organizations (CROs) as a means to remaining competitive and profitable.
Alliances and external collaborations have provided companies with the
opportunity to gain access to new technological breakthroughs and novel
expertise regardless of national or geographical boundaries. Evidence of the
growing emphasis on alliances and external collaborations as a route to success
is highlighted by the fact that partnerships within the biopharmaceutical sector
are currently being formed at the rate of $5 billion per year.
This new
report from Arrowhead Publishers is designed to provide information, insight and
in-depth analysis of alliance and licensing activity within the pharmaceutical
industry in order to identify the challenges faced by members of the
pharmaceutical community; current trends in partnering activity; an
understanding of the dynamics of the buyer-supplier relationship and best
practices for managing external collaborations. The report is aimed at providing
an appraisal of the partnering process, and insights into the current
environment of pharmaceutical discovery and development.
Strategies for
Innovation in Pharmaceutical R&D includes the following features:
• A
thorough market analysis of the global pharmaceutical industry, including the
challenges faced by pharmaceutical manufacturers and the technological
developments currently affecting innovation
• Guidelines for partnership
management, with profiles of market leaders in the areas of pharmaceuticals,
biotechnology and clinical research
• An informative and vital source of
reference that provides practitioners with easy to access case studies, tabular
data, key competitor profiles and a glossary of key pharmaceutical terms and
definitions, with details of alliance and licensing deals within the
biopharmaceutical sector
• A review of key developments taking place in the
environment of pharmaceutical R&D and an evaluation of possible strategies
for facilitating the drug discovery and development process
• Analysis of the
significance of biotechnology to the pharmaceutical industry, including key
trends in pharmaceutical alliance and licensing agreements
• An assessment of
the importance of outsourcing to the drug development process, and an overview
of the market for contract research, including key trends in pharmaceutical
licensing agreements
Contact:
Sales Department
952-474-5203
www.arrowheadpublishers.com
# # #
Source : http://www.prweb.com/releases/2005/3/prweb219520.htm